CAR-TCR Digital Summit Europe 2021

February 16–18, 2021
Meet us online at the CAR-TCR Digital Summit Europe.

Learn more about our solutions for clinical-grade CAR T cell manufacturing at the CAR-TCR Summit 
 

Bringing together large pharma, biotech, academia, and regulatory boards, the CAR-TCR Digital Summit Europe  is the definite platform to network, share ideas, and take part in sessions to advance novel cell products and overcome bottlenecks in developing CAR-TCR therapies. Join the European community of CAR and TCR drug developers and hear lessons learned to move your own pipeline towards clinical and commercial success. 

Don’t miss out on our talk ”Challenges and solutions for GMP-compliant CAR T cell manufacturing” and visit us in the virtual exhibit hall to learn how to harness closed system automation for the manufacturing of CAR T cells. Schedule a meeting with us within the virtual booth and see how we can support your vision in commercial-scale cell manufacturing.  

Scientific talk

Challenges and solutions for GMP-compliant CAR T cell manufacturing
 

The presentation reveals approaches to shorten needle-to-needle time while maintaining high intention-to-treat. Furthermore, we take a deeper look at the challenges around quality control (QC) and how closed, automated systems can help design new strategies. Last but not least, solutions towards increased gene-engineering complexity and their opportunities will be explained. 

 

Track: Manufacturing & Commercialisation
Wednesday, February 17,  2021
1:30 p.m.2:00 p.m. GMT
Presenter: Dr. Andrew Kaiser

Senior Manager R&D Cell & Gene Immunotherapy / Clinical Process Development, Miltenyi Biotec

Dr. Andrew Kaiser is a translational immunologist with a strong focus on the development of cell and gene immunotherapies against cancer and nearly 20 years experience in both academia and industry. He joined Miltenyi Biotec’s R&D in 2012, where he is now Senior Manager and leads several teams focusing on the implementation of effective cell and gene therapies. Efforts are more specifically driven towards developing tools and technologies for clinical applications of adoptive cell therapy through the automation of gene-modified T cell manufacturing; designing innovative molecular technologies to improve the clinical outcome of CAR T cells therapies; and bringing novel drugs to the clinic.

Learn more about our solutions for CAR T cells

Meet us at other events in 2021

Miltenyi Biotec Cell Therapy Analytics Day

SAVE THE DATE – May 19, 2021

A dedicated platform to discuss the latests technologies on cell therapy analytics. Meet the experts, exchange ideas, and discover how to simplify your cell manufacturing analytics. 

This event will be free of charge. Agenda and details to come soon!

CAR-TCR Summit Boston 2021

August 31–September 2, 2021

The 6th CAR-TCR Summit will return in 2021 as the industry-leading comprehensive forum bringing together CAR and TCR experts from pharma, biotech and academia. The event will provide you with networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. 

Learn more